Anika Therapeutics, Inc.

Anika Therapeutics, Inc.verified

ANIK

Price:

$16.97

Market Cap:

$248.54M

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone prese...[Read more]

Industry

Medical - Devices

IPO Date

1993-05-03

Stock Exchange

NASDAQ

Ticker

ANIK

The Current Ratio as of November 2024 (TTM) for Anika Therapeutics, Inc. (ANIK) is 5.34

According to Anika Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.34. This represents a change of -3.44% compared to the average of 5.53 of the last 4 quarters.

Anika Therapeutics, Inc. (ANIK) Historical Current Ratio (quarterly & annually)

How has ANIK Current Ratio performed in the past?

The mean historical Current Ratio of Anika Therapeutics, Inc. over the last ten years is 12.29. The current 5.34 Current Ratio has changed 4.24% with respect to the historical average. Over the past ten years (40 quarters), ANIK's Current Ratio was at its highest in in the March 2015 quarter at 23.70. The Current Ratio was at its lowest in in the March 2021 quarter at 3.69.

Quarterly (TTM)
Annual

Average

12.29

Median

12.35

Minimum

4.81

Maximum

23.27

Anika Therapeutics, Inc. (ANIK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Anika Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 128.40%

Maximum Annual Current Ratio = 23.27

Minimum Annual Increase = -66.78%

Minimum Annual Current Ratio = 4.81

Quarterly (TTM)
Annual
YearCurrent RatioChange
20235.26-13.43%
20226.077.38%
20215.6617.56%
20204.81-66.78%
201914.48-19.43%
201817.9813.90%
201715.78-18.52%
201619.3789.69%
201510.21-56.13%
201423.27128.40%

Anika Therapeutics, Inc. (ANIK) Average Current Ratio

How has ANIK Current Ratio performed in the past?

The current Current Ratio of Anika Therapeutics, Inc. (ANIK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

5.66

5-year avg

7.26

10-year avg

12.29

Anika Therapeutics, Inc. (ANIK) Current Ratio vs. Peers

How is ANIK’s Current Ratio compared to its peers?

Anika Therapeutics, Inc.’s Current Ratio is greater than AxoGen, Inc. (3.74), greater than Orthofix Medical Inc. (2.39), greater than Surmodics, Inc. (3.96), greater than Paragon 28, Inc. (3.50), greater than Artivion, Inc. (1.88), less than Sight Sciences, Inc. (10.18), greater than Avanos Medical, Inc. (2.22), less than OrthoPediatrics Corp. (7.17), less than NeuroPace, Inc. (5.59), less than CVRx, Inc. (11.32), greater than ProSomnus, Inc. Common Stock (0.30), less than Heska Corporation (6.70),

Build a custom stock screener for Anika Therapeutics, Inc. (ANIK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anika Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Anika Therapeutics, Inc. (ANIK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Anika Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Anika Therapeutics, Inc.'s Current Ratio?

How is the Current Ratio calculated for Anika Therapeutics, Inc. (ANIK)?

What is the highest Current Ratio for Anika Therapeutics, Inc. (ANIK)?

What is the 3-year average Current Ratio for Anika Therapeutics, Inc. (ANIK)?

What is the 5-year average Current Ratio for Anika Therapeutics, Inc. (ANIK)?

How does the current Current Ratio for Anika Therapeutics, Inc. (ANIK) compare to its historical average?